eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Check drugs       Compare drugs       Join a support group

From FDA reports: drug interactions between Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil for a Male patient aged 47

This is a personalized study for a 47 year old male patient. The study is created by eHealthMe based on reports of 122 people who take the same drugs and have drug interactionsfrom FDA.

On Mar, 27, 2015: 122 people who reported to have interactions when taking Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil are studied

Trend of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil's drug interactions, side effects, and effectiveness reports (3160959)

Information of the patient in this study:

Age: 47

Gender: male

Conditions: Prophylaxis Against Transplant Rejection

Drugs taking:
- Cellcept
- Tacrolimus
- Cyclophosphamide
- Methylprednisolone Sodium Succinate
- Alprostadil

Drug interactions have: Hepatic Neoplasm Malignant Recurrent

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 47 (±5):

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent6 (85.71%)

Most common interactions experienced by males aged 47 (±5) in the use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent6
Systemic Inflammatory Response Syndrome6
Pyrexia6
Metastases To Central Nervous System4
Visual Field Defect4
Cytomegalovirus Test Positive4
Depression4
Condition Aggravated4
Bronchopulmonary Aspergillosis4
Anaemia4

Most common interactions experienced by males aged 47 (±5) in long term use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Metastases To Bone2
Metastases To Central Nervous System2
Hepatic Neoplasm Malignant Recurrent2
Metastases To Abdominal Cavity2
Visual Field Defect2
Headache2
Visual Pathway Disorder2

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent6 (4.92%)

Most common interactions experienced by people in the use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Diarrhoea72
Acute Graft Versus Host Disease In Skin52
Cytomegalovirus Viraemia46
Pyrexia46
Neutropenia42
Pruritus36
Acute Graft Versus Host Disease32
Bronchopulmonary Aspergillosis30
Staphylococcal Sepsis30
Headache30

Most common interactions experienced by people in long term use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent3
Metastases To Central Nervous System3
Headache3
Metastases To Bone3
Metastases To Abdominal Cavity3
Visual Field Defect3
Oropharyngeal Pain2
Drug Interaction2
Arterial Thrombosis2
Visual Pathway Disorder2

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

 

 

 

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.